The Art and Science of Selecting a CD123-Specific Chimeric Antigen Receptor for Clinical Testing

Chimeric antigen receptor (CAR) T cells targeting CD123, an acute myeloid leukemia (AML) antigen, hold the promise of improving outcomes for patients with refractory/recurrent disease. We generated five lentiviral vectors encoding CD20, which may serve as a target for CAR T cell depletion, and 2nd o...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Janice M. Riberdy, Sheng Zhou, Fei Zheng, Young-In Kim, Jennifer Moore, Abishek Vaidya, Robert E. Throm, April Sykes, Natasha Sahr, Challice L. Bonifant, Byoung Ryu, Stephen Gottschalk, Mireya Paulina Velasquez
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2020-09-01
Saila:	Molecular Therapy: Methods & Clinical Development
Gaiak:	immunotherapy CAR T cell therapy AML CD123 leukemia
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2329050120301480
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!